Overview
- Peer‑reviewed results published in Nature Biotechnology describe autonomous delivery and operation of the tiny devices in mouse brains.
- Electronics were chemically fused to monocytes, allowing immune camouflage and trafficking to inflammation‑targeted regions across the intact barrier.
- After self‑implantation, an external near‑infrared transmitter powered the chips to provide highly localized electrical stimulation.
- Biocompatibility tests indicated the implants integrated among neurons without detectable effects on cognition or motor function.
- The research team launched Cahira Technologies and says it aims to pursue human trials in about three years, contingent on larger‑animal studies, long‑term safety data, and regulatory review.